30-Year Follow-Up Study in Patients with Lone Atrial Fibrillation Arshad jahangir, MD; Victor Lee, MBBS; Paul A. Friedman, MD; Jane M. Trusty, RN; David.

Slides:

Advertisements

Similar presentations

© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American.

Advertisements

1 GRASP-AF Audit - Intro 8 th July 2010 Mark Gregory.

Screening and diagnosis of AF and stratifying stroke risk.

THE IMPACT OF ATRIAL FIBRILLATION IN CARDIAC SURGERY Wim J De Vries. DEPARTMENT CARDIOTHORACIC SURGERY UNIVERSITY OF THE FREE STATE UNIVERSITAS HOSPITAL.

Does Preoperative Hemoglobin Value Predict Postoperative Cardiovascular Complications after Total Joint Arthroplasty? Kishor Gandhi MD, MPH, Eugene Viscusi.

Project Objective To enhance the system of care for atrial fibrillation that not only reduces system costs, but improves the experiences of both patients.

Valsartan Antihypertensive Long-Term Use Evaluation Results

Automatic QRS Complex Detection Algorithm Designed for a Novel Electrocardiogram Recording Device Co-authors Kenneth Egstrup, OUH Svendborg Hospital Jens.

Etiology distribution of patients with atrial fibrilation by echocardiography: results from a prospective study in 3755 adults Enes Abdovic Cantonal Hospital.

Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.

Study by: Granger et al. NEJM, September 2011,Vol No. 11 Presented by: Amelia Crawford PA-S2 Apixaban versus Warfarin in Patients with Atrial Fibrillation.

Peking University Dayi Hu Sept 16, IHF,Beijing, 2005 Atrial Fibrillation in China.

“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,

Evidence That D-dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients with Atrial Fibrillation during Oral Anticoagulant.

Katheterablatie van atriumfibrilleren Waar staan we? Lukas Dekker.

Epidemiology of Stroke Dexter L. Morris, PhD, MD Department of Emergency Medicine University of North Carolina School of Medicine Chapel Hill, NC.

Late outcomes of the Cox-Maze IV procedure for atrial fibrillation Matthew C. Henn MD, Timothy S. Lancaster MD, Jacob R. Miller MD, Laurie A. Sinn RN,

Maximum home blood pressure: a novel indicator of target-organ damage in hypertension  Blood pressure variability has recently been shown to be a strong.

Schwamm et al. Circulation epub April 6Schwamm et al. Race/Ethnicity, Quality of Care, and Outcomes in Ischemic Stroke Lee H. Schwamm, MD; Mathew.

Cognitive Impairment: An Independent Predictor of Excess Mortality SACHS, CARTER, HOLTZ, ET AL. ANN INTERN MED, SEP, 2011;155: ZACHARY LAPAQUETTE.

Multiple risk factors raise ischaemic stroke risk comparable to AF in the elderly: A large Chinese insurance analysis from 425,600 Chinese individuals.

Author Disclosures Differences in Implantation-Related Adverse Events Between Men and Women Receiving ICD Therapy for Primary Prevention Differences in.

Specialized Atrial Fibrillation Clinic reduces cardiovascular morbidity and mortality in patients with atrial fibrillation Jeroen ML Hendriks, MSc Robert.

Global Variations in the 1-year Rates of Death and Stroke in Patients Presenting to the Emergency Department with Atrial Fibrillation Results from the.

Meredith Cook – PharmD Candidate Mercer University COPHS August, 2012 Cognitive Trajectories after Postoperative Delirium.

Clinical Symptoms of Atrial Fibrillation in Different Ranges of QRS Duration Burda I.Yu., Yabluchansky N.I. Medical Clinics Chair National University of.

Does the Choice of Antihypertensive Agent Affect Risk for AFib? Summary and Comment by Joel M. Gore, MD Published in Journal Watch Cardiology February.

Redo afib ablation John R Onufer MD FHRS

Characteristics of patients included in the OCSP cohort used to derive the risk score and the three other cohorts used to validate the score P.M. Rothwell,et.

Strokes in Ascending Aortic Repairs: Predictive and Protective Factors Tovy Kamine, BS, Steven R Messé, MD, Elizabeth Leitner, Joseph Bavaria, MD, Michael.

Long-term mortality after acute stroke  Stroke is a leading cause of mortality: 6 million fatal events annually worldwide.  Mainly affects elderly, but.

Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.

VBWG Predictor of CV Events and Mortality in Postmenopausal Women: Leukocyte Count.

A Contemporary Analysis of Pulmonary Hypertension in Patients Undergoing Mitral Valve Surgery: Is this a Risk Factor? Thank you to the society and panel.

Feasibility & Safety of Dabigatran vs Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation:

Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.

Etiological Distribution of Chronic and Transient Atrial Fibrillation in Patients at Cantonal Hospital Zenica Enes Abdović 10 yrs Prospective Study, 29.

Long-Term Complications and Mortality in Young-Onset Diabetes Type 2 diabetes is more hazardous and lethal than type 1 diabetes Featured Article: Maria.

The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.

Interactions Between COPD and Outcomes After Percutaneous Coronary Intervention Tomas Konecny, Krishen Somers, Marek Orban, Yuki Koshino, Ryan J. Lennon,

Location of Thrombus in Non-Rheumatic Atrial Fibrillation SettingNAppendage(%) LA Body (%)Ref. TEE (21%) 1 (0.3%) Stoddard; JACC ’95 TEE233.

R2. 최태웅 / Pf. 김진배. BACKGROUND  Ischemic stroke : leading causes of death and disability : cause remains unexplained after routine evaluation → Cryptogenic.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Epidemiology and natural history of atrial fibrillation:

The Link Between Persistent Atrial Fibrillation and Dementia

Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? Renato D. Lopes, MD,

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated with Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.

Is There a Need to Address AF in patients Undergoing Valve Surgery?

Early Recovery of Left Ventricular Systolic Function After CoreValve Transcatheter Aortic Valve Replacement Harold L. Dauerman, MD; Michael J. Reardon,

Screening and diagnosis of AF and stratifying stroke risk

Alina M. Allen MD, Patrick S. Kamath MD, Joseph J. Larson,

A population-based cohort study of the influence of socioeconomic factors and race on survival in Merkel cell carcinoma Reshmi Madankumar, MD, Maressa.

with type 2 diabetes without heart failure?

Stroke and the obstructive Sleep Apnea patient

Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? Renato D. Lopes, MD,

Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.

Samir R. Kapadia, MD On behalf of The PARTNER Trial Investigators

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

How to Optimize TAVR Outcomes

Assessment of Allogeneic HCT in Older Patients with AML and MDS: A CIBMTR Analysis McClune B et al. ASCO/ASH Symposium 2009;The Best of ASH Special & Plenary.

Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.

A population-based cohort study of the influence of socioeconomic factors and race on survival in Merkel cell carcinoma Reshmi Madankumar, MD, Maressa.

Pradaxa Jeopardy Copyright 2001.

Risk Factor Modification

Amir Jadidi et al. JACEP 2018;4:

Stavros Stavrakis et al. JACEP 2015;1:1-13

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

Yoko Miyasaka, MD, PhD, Marion E. Barnes, MSc, Bernard J

Influence of Preoperative Atrial Fibrillation on Late Results of Mitral Repair: Is Concomitant Ablation Justified? Dumbor L. Ngaage, MB, FRCS(C-Th),

Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.

Left Atrial Fibrosis Assessed with Cardiac MRI in Patients with Paroxysmal and Those with Persistent Atrial Fibrillation More than two left atrial segments.

Presentation transcript:

30-Year Follow-Up Study in Patients with Lone Atrial Fibrillation Arshad jahangir, MD; Victor Lee, MBBS; Paul A. Friedman, MD; Jane M. Trusty, RN; David O.Hodge, MS; Stephen L. Kopecky, MD; Douglas L. Packer, MD; Stephen C. Hammil, MD; Win-Kuang Shen, MD; Bernard J. Gersh, MBChB, DPhil.

This study was conducted to: This study was conducted to: Investigate the potential predictors in patients with intermittent atrial fibrillation who progress to permanent atrial fibrillation. Evaluate the associated comorbidities and their implication in the progression and complications in patients with lone atrial fibrillation in relation to a similar matched population. 30-Year Follow-Up Study in Patients with Lone Atrial Fibrillation: Objectives

71 patients Paroxismal AFib (n=34) Persistent AFib (n=37) Persistent AFib (n=5) - excluded Median age 44  11 yr No SHD/no HTN Mean F-U 30 yr 71 patients Paroxismal AFib (n=34) Persistent AFib (n=37) Persistent AFib (n=5) - excluded Median age 44  11 yr No SHD/no HTN Mean F-U 30 yr 30-Year Follow-Up Study in Patients with Lone Atrial Fibrillation Jahangir, Friedman et al, Circ 2007

Natural History of Lone Atrial Fibrillation Jahangir, Friedman et al, Circ 2007 Cumulative Survival Survival from death (%) Expected Observed P=0.120 Years after diagnosis of AFib

CP Cumulative Survival Free of Stroke/TIA Years after diagnosis of AFib Survival free of stroke/TIA (%) Expected Observed P=0.014 Natural History of Lone AFib (Stroke/TIA) Jahangir, Friedman et al, Circ 2007

Cumulative Survival Survival from death (%) Expected Observed P=0.120 Years after diagnosis of AFib Cumulative Survival Free of Stroke/TIA Survival free of stroke/TIA (%) Expected Observed P= patients Median age 44  11 yr Paroxysmal AFib No SHD/no HTN Mean F-U 30 yr 71 patients Median age 44  11 yr Paroxysmal AFib No SHD/no HTN Mean F-U 30 yr Jahangir et al CP Expected Observed P=0.014 Age Development of hypertension Multivariate analysis Predictors of stroke/TIA Years after diagnosis of AFib Natural History of Lone AFib (Stroke/TIA)

Older age is an independent predictor of progression from paroxysmal to permanent lone atrial fibrillation, as well as an univariate predictor of increased mortality and cardiac mortality rates. Older age is an independent predictor of progression from paroxysmal to permanent lone atrial fibrillation, as well as an univariate predictor of increased mortality and cardiac mortality rates. Associated comorbidities influence the progression and risk of complications in patients with Atrial Fibrillation. Associated comorbidities influence the progression and risk of complications in patients with Atrial Fibrillation. 30-Year Follow-Up Study in Patients with Lone Atrial Fibrillation: Conclusions